National Institutes of Health
Precision Approaches in Radiation Synthetic Combinations (PAIRS, RP1 Clinical Trial Optional)
Precision Approaches in Radiation Synthetic Combinations (PAIRS, RP1 Clinical Trial Optional) is a funding opportunity from National Institutes of Health, closing November 11, 2026.
Overview
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits research projects that investigate actionable synthetic vulnerabilities that can be conditionally paired with tumor responses to radiation therapy. The goal of the Precision Approaches in Radiation Synthetic Combinations…